title: Authors' reply: cyclosporine A versus tacrolimus in steroid withdrawal strategies.
authors.forename: Julio
authors.initials: J
authors.lastname: Pascual
authors.forename: Ana
authors.initials: A
authors.lastname: Royuela
authors.forename: Javier
authors.initials: J
authors.lastname: Zamora
mesh_terms: D000075202:Contraindications; D016572:Cyclosporine / Q000627:therapeutic use*; D006084:Graft Rejection / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016030:Kidney Transplantation / Q000276:immunology*; D012307:Risk Factors; D013256:Steroids / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use*; D013997:Time Factors; D028761:Withholding Treatment
chemical_list: D007166:Immunosuppressive Agents; D013256:Steroids; D016572:Cyclosporine; D016559:Tacrolimus